✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic PolicyDeaRegulationAccessResearch Why This MattersThe DEA's scheduling decisions directly impact patient access to cannabis medicine...
Cannabis rescheduling testimony in Congress (Newsletter: April 7, 2026)
✦ New CED Clinical Relevance #55 Clinical Context Background information relevant to the evolving cannabis medicine landscape. PolicyResearchMental Health Clinical Summary A former Indiana attorney general has publicly opposed Governor Mike Braun's...
Marijuana Rescheduling Countdown: Why the "Order of Operations" and Todd Blanche’s …
✦ New CED Clinical Relevance #62 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. PolicyResearchSafetyIndustry Why This Matters Rescheduling cannabis could accelerate clinical trial timelines by removing regulatory barriers...
Man sentenced to at least 25 years after skipping trial – FOX34
✦ New CED Clinical Relevance #80High Clinical Relevance Strong evidence or policy relevance with direct clinical implications. ⚒ Cannabis News | CED Clinic Not Applicable Why This MattersThis news item lacks any cannabis-related content or clinical...
The Great Misclassification Caper: Why The Confusion Persists – Fathom Journal
✦ New CED Clinical Relevance #60Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic PolicyRegulationMedical CannabisResearchClinical Practice Why This MattersCannabis classification remains a fundamental barrier to clinical research...
Marijuana Rescheduling Could ‘Unlock Research’ To Treat Rare Diseases, Father Of …
✦ New CED Clinical Relevance #72 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. PolicyResearchRare Diseases Why This Matters Rescheduling cannabis from Schedule I to a lower DEA schedule...
Verdict watch: Day 2 of deliberations in Mid-State murder trial – CNY Central
✦ New CED Clinical Relevance #80High Clinical Relevance Strong evidence or policy relevance with direct clinical implications. ⚒ Cannabis News | CED Clinic Non-Applicable Why This MattersThis appears to be a general news item about criminal...
Rescheduling Cannabis Under the Controlled Substances Act | The Regulatory Review
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic PolicyRegulationResearchFederal LawClinical Practice Why This MattersRescheduling cannabis from Schedule I to a lower schedule...
Innovative Industrial Properties: Deeply Undervalued As Cannabis Rescheduling Hits Milestone
✦ New CED Clinical Relevance #80High Clinical Relevance Strong evidence or policy relevance with direct clinical implications. ⚒ Cannabis News | CED Clinic RegulationPolicyResearchFederal LawClinical Practice Why This MattersCannabis rescheduling from Schedule I to Schedule III...
US Congressman Presses DOJ, DEA Heads on Cannabis Rescheduling Timeline
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic PolicyResearchFederal RegulationMedical CannabisDrug Scheduling Why This MattersCannabis rescheduling from Schedule I to Schedule III...